Biotech

All Articles

Repare gives up 25% of workers as biotech standstills preclinical R&ampD

.Repare Therapeutics is actually giving up an one-fourth of its staff as the oncology biotech scales...

J &amp J apply for FDA authorization of $6.5 B autoimmune medicine

.Johnson &amp Johnson has taken yet another measure toward realizing a gain on its own $6.5 billion ...

Gain's stage 1 gain leads method to verify Parkinson's medication's worth

.Increase Rehabs has set its sights on verifying the performance of its own Parkinson's ailment trea...

Actinogen documents brand new phase 2 records to salvage anxiety medication

.Actinogen Medical's hopes-- and stock cost-- have actually recoiled somewhat coming from earlier th...

Pfizer and also Flagship include Ratio to multibillion-dollar formula

.Crown Jewel Pioneering and also Pfizer have actually added Ratio right into their 10-program partne...

Bayer markers $547M treaty to drive limits of noncoding RNA

.Bayer execs were actually eager to tension to Brutal this summer months that the German pharma tita...

UK reveals plans to launch 18 brand new medical test centers

.Amidst a yearslong clinical test decline in the U.K., a brand-new public-private collaboration has ...

UPDATE: Genentech telegrams 93 unemployments in California after sharing programs to shutter cancer immunology research study unit

.Observing the statement of a huge cutback round in April and a significant restructuring campaign i...

Neurocrine's KarXT competitor hits in phase 2-- but only at low dose

.Neurocrine Biosciences has actually attained its own hoped-for profile in a stage 2 schizophrenia t...

Vaderis' unusual capillary problem drug lowers nosebleeds

.Vaderis Therapies' target to cultivate the first medicine aimed especially at a certain rare capill...